Study of Outcome of Children Previously Enrolled in European Trials of Treatment for Primitive Neuroectodermal Tumour (PNET)
- Determine the quality of survival of patients in the UK and other European countries
enrolled in previous International Society of Pediatric Oncology (SIOP) 2 or 3 phase
III trials for treatment of pediatric primitive neuroectodermal tumors (PNET).
- Compare the quality of survival between children allocated to different treatments in
- Determine the framework that will allow similar information to be collected across all
participating countries in the PNET 4 trial that opened in autumn 2002.
OUTLINE: This is a cross-sectional, multicenter study.
Pediatric oncologists, teachers, patients ≥ 12 years old, and parents of children age 3-11
years old complete six questionnaires to assess the patients' motor and sensory function,
cognition, behavior, emotion, educational provision and achievement, social integration, and
the subjective experience of the patients and their families.
PROJECTED ACCRUAL: A total of 229 patients will be accrued for this study.
Quality of life (QOL) as measured by QOL questionnaire
University Hospital Southampton NHS Foundation Trust.
United States: Federal Government